Associate Professor of Plastic and Reconstructive Surgery, Department of Surgical Science, "Tor Vergata" University, 00173, Via Montpellier 1, Rome 00133, Italy; Scientific Director of Academy of International Regenerative Medicine and Surgery Societies (AIRMESS), Geneva 1201, Switzerland.
Institute of Dermatology, F. Policlinico Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome 00168 Italy.
J Plast Reconstr Aesthet Surg. 2022 Feb;75(2):850-859. doi: 10.1016/j.bjps.2021.11.004. Epub 2021 Nov 13.
The number of clinical trials evaluating platelet-rich plasma (PRP) efficacy in female androgenetic alopecia (F-AGA) has exponentially increased during the last five years. A systematic review focused on this specific field has been performed by assessing the local infiltrations of PRP compared with any control for F-AGA in the selected studies.
The aim of this study was to evaluate the safety and efficacy of the use of PRP in F-AGA.
The protocol was developed in accordance with the Preferred Reporting for Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) guidelines. A multistep search of PubMed, MEDLINE, Embase, PreMEDLINE, Ebase, CINAHL, PsycINFO, Clinicaltrials.gov, Scopus database, and Cochrane databases has been performed to identify papers on female pattern hair loss (FPHL) treatment with PRP. Of the 63 articles initially identified, 11 articles focusing on AGA were selected and, consequently, only 5 articles focused exclusively on F-AGA were analyzed. Of this amount, 3 articles were randomized-controlled trials (RCTs), 1 clinical trial, and 1 double-blind placebo-controlled pilot study (DBPCPS). The studies included had to match predetermined criteria according to the PICOS (patients, intervention, comparator, outcomes, and study design) approach.
Eight percent of the articles selected and analyzed, reported a positive effect of PRP for F-AGA treatment. The information analyzed highlights the positive effects of PRP on F-AGA, without major side effects and thus, it may be considered as a safe and effective alternative procedure to treat hair loss compared with traditional drugs as Minoxidil® and Finasteride®.
The use of PRP in F-AGA was safe and effective for F-AGA.
在过去五年中,评估富含血小板血浆(PRP)治疗女性雄激素性脱发(F-AGA)疗效的临床试验数量呈指数级增长。通过评估所选研究中 PRP 与任何对照药物在 F-AGA 中的局部浸润情况,对这一特定领域进行了系统评价。
本研究旨在评估 PRP 在 F-AGA 中的安全性和疗效。
该方案按照系统评价和荟萃分析报告项目的首选报告(PRISMA-P)指南制定。通过对 PubMed、MEDLINE、Embase、PreMEDLINE、Ebase、CINAHL、PsycINFO、Clinicaltrials.gov、Scopus 数据库和 Cochrane 数据库进行多步骤搜索,以确定关于 PRP 治疗女性型脱发(FPHL)的论文。最初确定的 63 篇文章中,有 11 篇文章专注于 AGA,随后仅分析了 5 篇专门针对 F-AGA 的文章。其中,3 篇为随机对照试验(RCT),1 篇临床试验,1 篇双盲安慰剂对照初步研究(DBPCPS)。所选研究必须根据 PICOS(患者、干预、对照、结局和研究设计)方法符合预定标准。
分析的文章中,有 8%报道了 PRP 治疗 F-AGA 的积极效果。分析的信息强调了 PRP 对 F-AGA 的积极作用,没有出现重大副作用,因此,与米诺地尔®和非那雄胺®等传统药物相比,它可能被视为一种安全有效的脱发治疗替代方法。
PRP 治疗 F-AGA 安全有效。